PRTN3 and rheumatoid arthritis: Various authors throughout the world have proposed that RF and ACPA are markers of the severity of RA, increased radiographic progression and joint damage.[25–27] However, in the context of treatment with anti-TNF alpha drugs, it is essential to determine factors that enable us to predict prognosis.